MMA
TMO icon

Miracle Mile Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Miracle Mile Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.88M Sell
5,748
-46
-0.8% -$22.1K 0.03% 277
2026
Q1 		$2.85M Sell
5,794
-109
-2% -$59.2K 0.04% 260
2025
Q4 		$3.42M Buy
5,903
+311
+6% +$176K 0.05% 235
2025
Q3 		$2.71M Sell
5,592
-86
-2% -$40K 0.04% 262
2025
Q2 		$2.3M Buy
5,678
+75
+1% +$31.4K 0.04% 241
2025
Q1 		$2.79M Buy
5,603
+93
+2% +$50.4K 0.06% 186
2024
Q4 		$2.87M Sell
5,510
-405
-7% -$223K 0.06% 179
2024
Q3 		$3.66M Buy
5,915
+155
+3% +$91.8K 0.08% 132
2024
Q2 		$3.19M Buy
5,760
+320
+6% +$183K 0.08% 145
2024
Q1 		$3.16M Buy
5,440
+121
+2% +$67.9K 0.08% 150
2023
Q4 		$2.82M Sell
5,319
-1,150
-18% -$557K 0.08% 148
2023
Q3 		$3.27M Buy
6,469
+12
+0.2% +$6.39K 0.1% 127
2023
Q2 		$3.37M Sell
6,457
-236
-4% -$127K 0.1% 131
2023
Q1 		$3.86M Sell
6,693
-461
-6% -$260K 0.12% 129
2022
Q4 		$3.94M Buy
7,154
+2,937
+70% +$1.56M 0.14% 134
2022
Q3 		$2.14M Buy
4,217
+132
+3% +$73.9K 0.1% 141
2022
Q2 		$2.22M Sell
4,085
-633
-13% -$348K 0.1% 139
2022
Q1 		$2.79M Sell
4,718
-5,208
-52% -$2.99M 0.12% 132
2021
Q4 		$6.62M Buy
9,926
+305
+3% +$190K 0.26% 81
2021
Q3 		$5.5M Buy
9,621
+171
+2% +$93.9K 0.26% 80
2021
Q2 		$4.77M Buy
9,450
+52
+0.6% +$24.5K 0.25% 77
2021
Q1 		$4.29M Buy
9,398
+5,854
+165% +$2.79M 0.24% 86
2020
Q4 		$1.65M Buy
3,544
+524
+17% +$246K 0.1% 163
2020
Q3 		$1.33M Buy
3,020
+1,890
+167% +$781K 0.09% 161
2020
Q2 		$409K Sell
1,130
-110
-9% -$36.9K 0.03% 239
2020
Q1 		$352K Buy
1,240
+163
+15% +$51.4K 0.04% 205
2019
Q4 		$350K Buy
1,077
+33
+3% +$10K 0.02% 226
2019
Q3 		$304K Buy
1,044
+309
+42% +$88.5K 0.02% 231
2019
Q2 		$216K Hold
735
– – 0.02% 244
2019
Q1 		$201K Buy
+735
New +$183K 0.02% 251

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Miracle Mile Advisors's TMO Position: Q2 2026 in Review

Miracle Mile Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.79% in Q2 2026, selling an estimated $22.1K and leaving 5,748 shares worth $2.88M. The position accounts for 0.03% of the portfolio, ranked #277.

Miracle Mile Advisors first reported a position in TMO in Q1 2019 and has held it in 30 quarters since. The position peaked at $6.62M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Miracle Mile Advisors held 5,748 shares of Thermo Fisher Scientific worth $2.88M as of Q2 2026.
  • Miracle Mile Advisors sold 46 Thermo Fisher Scientific shares in Q2 2026, an estimated $22.1K.
  • Thermo Fisher Scientific made up 0.03% of Miracle Mile Advisors's portfolio in Q2 2026, its #277 holding.
  • Miracle Mile Advisors first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 30 quarters since.
  • Miracle Mile Advisors's Thermo Fisher Scientific position peaked at $6.62M in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.